Current Affairs · Intellectual Property Rights
मार्च 2023 में, भारत ने भारतीय पेटेंट कानून की धारा 3(d) का हवाला देते हुए, जॉनसन एंड जॉनसन द्वारा तपेदिक (टीबी) की किस दवा के निर्माण पर अपने एकाधिकार को बढ़ाने के प्रयास को खारिज कर दिया था?
Verified Solution4 OptionsUpdated: October 2026👁️1 View
Share:
- 1एथमब्यूटोल (Ethambutol)
- 2आइसोनियाज़िड (Isoniazid)
- 3बेडाक्विलाइन (Bedaquiline)✓
- 4रिफैम्पिन (Rifampin)
सही उत्तर देखें
बेडाक्विलाइन (Bedaquiline)
Download Single Question PDF
Save this question and verified answer as a clean study sheet with live clickable link.
👥
Share with Friends & Study Groups
Challenge your peer aspirants on WhatsApp or Telegram to solve this question!
Online Test Series
Start Free Mock Test →Preparing for Current Affairs?
Practice full-length mock tests with real exam timers, instant score analysis, and all-India ranking.
Chapter Practice
Practice Intellectual Property Rights MCQs →Want more practice questions on Intellectual Property Rights?
Solve complete topic-wise tests with detailed solutions on GkGet.
Related Practice Questions
Recommended practice questions in Current Affairs · Intellectual Property Rights